Table 8.

Predictors of survival in patients suffering from pyogenic liver abscess

	Univariate analysis		Multivariate analysis
Variables	OR (95% CI)	P value	OR (95% CI)	P value
Age	0.99 (0.95–1.04)	0.73
Male gender	0.86 (0.22–3.38)	0.83
Predisposing disease
Malignancy	0.22 (0.05–0.93)	0.04	0.19 (0.04–0.94)	0.041
Liver cirrhosis	0.77 (0.14–4.18)	0.77
Diabetes mellitus	1.38 (0.27–7.19)	0.70
Medication
Proton-pump inhibitor use	0.68 (0.13–3.52)	0.64
Immunosuppression	0.85 (0.16–4.57)	0.85
Blood values
C-reactive Protein	1.10 (0.98–1.23)	0.10
WBC	0.98 (0.91–1.06)	0.56
Bilirubin	0.85 (0.75–0.98)	0.02	0.85 (0.75–0.97)	0.015
Creatinine	0.63 (0.26–1.53)	0.30
INR	0.44 (0.10–1.99)	0.29
Cholangitis	0.19 (0.04–0.98)	0.046
MDRO	0.75 (0.17–3.26)	0.70
Mycotic coinfection	0.41 (0.10–1.67)	0.22
Initial empirical antibiotic treatment
Carbapenem based	0.60 (0.15–2.33)	0.46
Glycopeptide based	1.12 (0.26–4.79)	0.88
Tigecycline based	0.79 (0.08–7.56)	0.84
Metronidazole based	2.89 (0.33–25.03)	0.33